Table 32. Financial indicators of SLLC Paula Stradiņa Klīniskā universitātes slimnīca Main financial indicators, EUR ‘000 Overall indicators
2014
2015
83 157.7
81 503.5
147.3
152.8
5 433.6
4 789.2
574.3
420.1
Total assets
103 841.5
104 719.0
Share capital
19 366.8
19 366.8
9 045.4
9 198.1
Profit and turnover ratio, %
0.2
0.2
EBITDA and turnover ratio, %
6.5
5.9
Turnover Profit/loss EBITDA EBIT
Equity Factors
Return on assets, ROA, %
0.1
0.1
Return on equity, ROE, %
1.6
1.7
Total liquidity indicator
3.4
2.8
Liabilities to equity ratio
10.5
10.4
2 993
2 926
11.9
12.5
11 902.4
15 664.5
0.0
0.0
All instalments in the budget (incl. dividends, taxes, fees)
17 291.2
18 087.5
Funding directly or indirectly received from the national budget (grants, fees for services and other financial products)
73 369.5
70 856.7
Other indicators Number of employees on average per year Gross remuneration, average per employee Investment in fixed assets Dividends from the profits of the previous year paid into the national budget
LLC Rīgas Austrumu klīniskā universitātes slimnīca LLC Rīgas Austrumu klīniskā universitātes slimnīca is the largest multipurpose medical treatment institution in Latvia that provides diverse diagnosis and treatment for patients, conducts scientific research work and creates innovations, ensures training of young professionals and implements measures to educate the society and promote health. LLC Rīgas Austrumu klīniskā universitātes slimnīca is a SOE where all shares belong to the State and the shareholder is the Ministry of Health. LLC Rīgas Austrumu klīniskā universitātes slimnīca ownreship in other enterprises: 99.58% in LLC Veselības centrs ‘’Biķernieki’’ and 51% in LLC Rīgas Hematoloģijas centrs. Individual clinics of the hospital provide in-house assistance in the fields, which are not available in other hospitals of Latvia, for example, treatment of microsurgery, plastic and reconstructive surgery, bedsore treatment, toxicology and sepsis, in polytrauma field, treatment of burns and frostbite, rehabilitation of people,
50
who were victims in national socialist regime, children hearing disorders, transplantation of stem cells, tuberculosis, treatment of HIV/AIDS, radiotherapy for oncology patients. The hospital owns six stationeries: Gaiļezers, Latvijas Onkoloģijas centrs, Biķernieki, Linezers, Latvijas Infektoloģijas centrs and Tuberkolozes un plaušu slimību centrs as well as Patoloģijas centrs. In 2015, 73 072 patients were treated at the hospital, which is by 477 patients more than in 2014. Regarding the treatment process efficiency towards the decrease in treatment costs without losing quality, LLC Rīgas Austrumu klīniskā universitātes slimnīca in 2015 had a decrease in average length of 24 hour inhouse treatment by 0.2 days that is from 8.1 days in 2014 to 7.9 days in 2015. Consequently, despite the larger number of patients, the number of bed days in the 24 hour treatment has reduced from 585 209 bed days in 2014 to 577 081 bed days in 2015. In 2015, 518 176 outpatient services were provided, which is by 12 575 more than in 2014. In 2015, LLC Rīgas Austrumu klīniskā universitātes slimnīca implemented several large-scale infrastructure development projects − ‘’Improvement of Hospital Health Care Infrastructure in Rīgas Austrumu klīniskā universitātes slimnīca’’ (No 3DP/3.1.5.3.1/11/ IPIA/VEC/010) with total funding of 14 216 008 euros. Within the framework of the project, reconstruction of the operation block was done in the area of 7 017.6 m2, creating 22 universal, high load operation rooms with large patient penetrability and the interior for radiology diagnosis rooms in area of 1 592 m2. In addition, delivery and installation of operation block technologies, radiotherapy server, x-ray equipment and ultrasound image patient examination system was performed. The second project that was implemented and completed − ‘’Improvement of Stationary Health Care’s Infrastructure in LLC Rīgas Austrumu klīniskā universitātes slimnīca’’ (No 3DP/3.1.5.3.1/11/ IPIA/VEC/001) with total funding of 3 586 856 euros. A large-scale reconstruction was implemented in the hospital Onkoloģijas centrs, and rooms were created for stem cell freezing and preservation, as well as technologies were bought.